Establishing mobile health clinics in rural settings requires collaboration across health systems by aligning missions, building infrastructure to support research, and demonstrating proof of concept.

Terms & Conditions Terms & Conditions This Statement was last revised [01/16/2026] TERMS AND CONDITIONS OF USE PLEASE READ THE FOLLOWING TERMS AND CONDITIONS OF USE (THE “TERMS”) CAREFULLY BEFORE ...

Deepak Bhatt, MD, MPH, MBA, discusses how new evidence, prevention definitions, and imaging advances are reshaping how PCSK9 ...

Evidence-Based Oncology ™ is a forum for the dissemination of clinical, pharmacoeconomic, and regulatory information to payers, health care policy experts, and providers associated with cancer care.

Analyses spanning 35,245 patients across 13 scenarios found comparable initiation of any systemic therapy in Medicare ...

Population Health, Equity & Outcomes is a quarterly publication dedicated to providing a platform for the exchange of research, policy analysis, and insights that aim to improve health outcomes and ...

Our family of journals—The American Journal of Managed Care®, Population Health, Equity & Outcomes, and Evidence-Based Oncology™—is seeking to publish timely research and commentary. Find the right ...

A 12-week prospective cohort enrolled 73 patients with guideline-based asthma or COPD and no speech-affecting comorbidities, ...

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia platforms.

Epcoritamab shows high rates of first-line response and MRD negativity in older patients with chemo-ineligible DLBCL, whether used alone or with R-mini-CHOP. Current sickle cell disease (SCD) trial ...

FDA approval establishes enlicitide as the first oral PCSK9 inhibitor for low-density lipoprotein cholesterol reduction, positioning it as a daily alternative to injectable PCSK9 agents. The approved ...